Shenrui Bai

4PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 30, 2026
LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial.

Jun Cai, Baitian Zhao, Dongmei Ji

|Oct 04, 2025
Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.

Liyun Qiu, Shenrui Bai, Jun Cai

|Apr 30, 2025
Clinical outcome of ≥2% circulating tumor cells in newly diagnosed multiple myeloma: insights from a multicenter study.

Dong Liang, Yurong Yan, Shenrui Bai

|Oct 18, 2024
Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study.

Dong Liang, Xiaojin Li, Shenrui Bai

Pageof 1

Frequent Collaborators

2 joint publications

Dong Liang

2 joint publications

Hua Wang

2 joint publications

Qingqing Cai

1 joint publications

Qiaoli Wang